ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,473Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 122

$503K Total Retail Price of All Prescriptions

Rank: 16 out of 122

348 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

14% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
SIMVASTATIN 376 336 1 1
LEVOTHYROXINE SODIUM 275 243 2 4
OMEPRAZOLE 273 247 3 3
FUROSEMIDE 245 224 4 5
HYDROCODONE-ACETAMINOPHEN 242 142 S3 5 16
HYDROCHLOROTHIAZIDE 237 229 6 6
AMLODIPINE BESYLATE 236 211 7 7
METOPROLOL TARTRATE 212 199 8 8
METOPROLOL SUCCINATE 178 157 9 11
WARFARIN SODIUM 152 126 10 9
CITALOPRAM HBR 144 114 11 15
POTASSIUM CHLORIDE 144 144 11 22
LOSARTAN-HYDROCHLOROTHIAZIDE 137 129 13 55
CRESTOR 134 130 14 37
METFORMIN HCL 123 94 15 14
ZOLPIDEM TARTRATE 122 104 16 19
LOVASTATIN 110 94 17 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 106 18 49
LOSARTAN POTASSIUM 105 99 19 17
LISINOPRIL 104 86 20 2
MORPHINE SULFATE ER 99 13 S2 21 42
ATORVASTATIN CALCIUM 98 88 22 13
DONEPEZIL HCL 92 81 23 25
OXYCODONE-ACETAMINOPHEN 91 87 S2 24 41
DIOVAN HCT 83 81 25 118
GABAPENTIN 83 49 25 12
GLIMEPIRIDE 83 54 25 51
TAMSULOSIN HCL 80 80 28 26
ATENOLOL 76 57 29 10
DIOVAN 75 75 30 40
PANTOPRAZOLE SODIUM 72 60 31 23
ISOSORBIDE MONONITRATE ER 69 69 32 44
DILTIAZEM 24HR CD 65 62 33 66
SPIRIVA 64 64 34 29
AZITHROMYCIN 60 52 35 53
ALLOPURINOL 58 50 36 33
COMBIVENT 51 39 37 60
PROAIR HFA 50 46 38 31
RISPERIDONE 50 50 38 64
RANITIDINE HCL 50 37 38 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.